منابع مشابه
Ristocetin and the thrombin clotting time.
The addition of the antibiotic ristocetin to plasma accelerated the thrombin clotting time (TCT) in 20 out of 22 subjects. Prior incubation of ristocetin with thrombin or plasma did not alter its effect on the TCT. Ristocetin accelerated clotting greatly at low but not at high levels of thrombin. A simple linear correlation between heparin concentrations and the TCT was demonstrated when ristoc...
متن کاملHigh dose thrombin time versus the activated clotting time during cardiopulmonary bypass.
In this study we compared the High Dose Thrombin Time (HiTT) with the Activated Clotting Time (ACT) during cardiopulmonary bypass (CPB) in non-aprotinin treated patients. On the advice of the HiTT test manufacturer each institution should perform comparative ACT/HiTT assays in the cardiac surgery population. In previous tests our target ACT value of 480 seconds corresponds with a mean HiTT valu...
متن کاملClotting Time and Reaction Velocity in the Interaction of Bovine Fibrinogen and Thrombin.
Radiocarbon Dates: J. B. Arnold and W. F. Libby..................................... 111 Technical Papers Clotting Time and Reaction Velocity in the Interaction of Bovine Fibrinogen and Thrombin: David F. Waugh and Betty J. Livingstone .121 Radiocarbon Age Measurements and Fossil Man in Mexico .-gelmut de Terra .124 Lipase from Molds Grown on Oil Seeds: C. V. Ramakrishna* and B. N. Banerjee .12...
متن کاملThe ecarin clotting time, a universal method to quantify direct thrombin inhibitors.
The ecarin clotting time (ECT) is a meizothrombin generation test that allows for precise quantification of direct thrombin inhibitors. The ECT has demonstrated its usefulness for more than 10 years in biochemical-pharmacological investigations as well as in clinical research and in the clinical routine. It has proved valuable especially as a drug-monitoring method in r-hirudin therapy. This te...
متن کاملReptilase and thrombin clotting time of plasma from patients treated with streptokinase.
Increasing clinical experience has gradually diminished the number of laboratory tests required for monitoring thrombolytic therapy. Still wider and wider use of plasminogen activators, often without a specialized laboratory basis, makes it imperative that some easily performed and reproducible tests should be at our disposal. Such conditions seem to be fulfilled by a simple assay of plasma clo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Pathology
سال: 1978
ISSN: 0021-9746
DOI: 10.1136/jcp.31.11.1106